Rämsby S - Search Results

1

Conformational properties of semirigid antipsychotic drugs: the pharmacophore for dopamine D-2 antagonist activity.

Froimowitz M, Rämsby S. Froimowitz M, et al. Among authors: ramsby s. J Med Chem. 1991 May;34(5):1707-14. doi: 10.1021/jm00109a026. J Med Chem. 1991. PMID: 1674541

2

Antidepressant agents. 1. Chemistry and pharmacology of amino-substituted spiro(5H-dibenzo(a,d)cycloheptene-5,1'-cycloalkanes).

Carnmalm B, Jacupovic E, Johansson L, de Paulis T, Rämsby S, Stjernström NE, Renyi AL, Ross SB, Ogren SO. Carnmalm B, et al. Among authors: ramsby s. J Med Chem. 1974 Jan;17(1):65-72. doi: 10.1021/jm00247a014. J Med Chem. 1974. PMID: 4543291 No abstract available.

3

Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides.

de Paulis T, Kumar Y, Johansson L, Rämsby S, Florvall L, Hall H, Angeby-Möller K, Ogren SO. de Paulis T, et al. Among authors: ramsby s. J Med Chem. 1985 Sep;28(9):1263-9. doi: 10.1021/jm00147a025. J Med Chem. 1985. PMID: 4040977

4

2-Haloaporphines as potent dopamine agonists.

Ramsby S, Neumeyer JL, Grigoriadis D, Seeman P. Ramsby S, et al. J Med Chem. 1989 Jun;32(6):1198-201. doi: 10.1021/jm00126a009. J Med Chem. 1989. PMID: 2524592

5

Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides.

de Paulis T, Kumar Y, Johansson L, Rämsby S, Hall H, Sällemark M, Angeby-Möller K, Ogren SO. de Paulis T, et al. Among authors: ramsby s. J Med Chem. 1986 Jan;29(1):61-9. doi: 10.1021/jm00151a010. J Med Chem. 1986. PMID: 3941414

6

New selective dopamine D-2 antagonists as antipsychotic agents. Pharmacological, chemical, structural and theoretical considerations.

Högberg T, Rämsby S, Ogren SO, Norinder U. Högberg T, et al. Among authors: ramsby s. Acta Pharm Suec. 1987;24(6):289-328. Acta Pharm Suec. 1987. PMID: 2898864 Review. No abstract available.

7

Antidepressant agents. 9. 3,3-Diphenylcyclobutylamines, a new class of central stimulants.

Carnmalm B, Rämsby S, Renyi AL, Ross SB, Ogren SO. Carnmalm B, et al. Among authors: ramsby s. J Med Chem. 1978 Jan;21(1):78-82. doi: 10.1021/jm00199a014. J Med Chem. 1978. PMID: 22757

8

Synthesis and pharmacology of potentially neuroleptic derivatives of 3-chloro-spiro[5H-dibenzo[a,d]cycloheptene-5,1'-cyclohex-2'-en]-4'-amine.

Rämsby S, Carnmalm B, Ogren SO, Stjernström NE. Rämsby S, et al. Acta Pharm Suec. 1979;16(3):166-72. Acta Pharm Suec. 1979. PMID: 39421 No abstract available.

9

Crystallographic, theoretical and molecular modelling studies on the conformations of the salicylamide, raclopride, a selective dopamine-D2 antagonist.

Högberg T, Norinder U, Rämsby S, Stensland B. Högberg T, et al. Among authors: ramsby s. J Pharm Pharmacol. 1987 Oct;39(10):787-96. doi: 10.1111/j.2042-7158.1987.tb05120.x. J Pharm Pharmacol. 1987. PMID: 2891816

10

Sedative 1,2,3-thiadiazoles.

Rämsby SI, Ogren SO, Ross SB, Stjernström NE. Rämsby SI, et al. Acta Pharm Suec. 1973 Sep;10(4):285-96. Acta Pharm Suec. 1973. PMID: 4759355 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results